The challenge of assuring continued post-trial access to beneficial treatment

MeSH terms

• Anti-HIV Agents / supply & distribution
• Clinical Trials as Topic / ethics*
• Continuity of Patient Care / ethics*
• Drugs, Investigational / administration & dosage
• Drugs, Investigational / supply & distribution*
• Ethics, Research*
• Global Health
• Guidelines as Topic
• Health Services Accessibility / ethics*
• Humans
• International Agencies
• International Cooperation*
• Moral Obligations*
• Quality Assurance, Health Care / ethics
• Therapeutic Human Experimentation / ethics*
• United States